225 related articles for article (PubMed ID: 35095863)
21. Autosomal recessive 333 base pair interleukin 10 receptor alpha subunit deletion in very early-onset inflammatory bowel disease.
Lv JJ; Su W; Chen XY; Yu Y; Xu X; Xu CD; Deng X; Huang JB; Wang XQ; Xiao Y
World J Gastroenterol; 2021 Nov; 27(44):7705-7715. PubMed ID: 34908808
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.
Crowley E; Warner N; Pan J; Khalouei S; Elkadri A; Fiedler K; Foong J; Turinsky AL; Bronte-Tinkew D; Zhang S; Hu J; Tian D; Li D; Horowitz J; Siddiqui I; Upton J; Roifman CM; Church PC; Wall DA; Ramani AK; Kotlarz D; Klein C; Uhlig H; Snapper SB; Gonzaga-Jauregui C; Paterson AD; McGovern DPB; Brudno M; Walters TD; Griffiths AM; Muise AM
Gastroenterology; 2020 Jun; 158(8):2208-2220. PubMed ID: 32084423
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
Zheng C; Huang Y; Hu W; Shi J; Ye Z; Qian X; Huang Z; Xue A; Wang Y; Lu J; Tang Z; Wu J; Wang L; Peng K; Zhou Y; Miao S; Sun H
Inflamm Bowel Dis; 2019 Mar; 25(4):756-766. PubMed ID: 30212871
[TBL] [Abstract][Full Text] [Related]
24. Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing.
Arunachalam AK; Maddali M; Aboobacker FN; Korula A; George B; Mathews V; Edison ES
J Clin Immunol; 2021 Feb; 41(2):393-413. PubMed ID: 33225392
[TBL] [Abstract][Full Text] [Related]
25. Compound heterozygous mutations in IL10RA combined with a complement factor properdin mutation in infantile-onset inflammatory bowel disease.
Jung ES; Petersen BS; Mayr G; Cheon JH; Kang Y; Lee SJ; Che X; Kim WH; Kim S; Schreiber S; Franke A; Koh H
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1491-1496. PubMed ID: 30199474
[TBL] [Abstract][Full Text] [Related]
26. Novel Compound Heterozygote Mutation in IL10RA in a Patient With Very Early-Onset Inflammatory Bowel Disease.
Oh SH; Sung YH; Kim I; Sim CK; Lee JH; Baek M; Pack CG; Seok C; Seo EJ; Lee MS; Kim KM
Inflamm Bowel Dis; 2019 Feb; 25(3):498-509. PubMed ID: 30462267
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Mutation Description of the First Iranian Cohort of Infantile Inflammatory Bowel Disease: The Iranian Primary Immunodeficiency Registry (IPIDR).
Rahmani F; Rayzan E; Rahmani MR; Shahkarami S; Zoghi S; Rezaei A; Aryan Z; Najafi M; Rohlfs M; Jeske T; Aflatoonian M; Chavoshzadeh Z; Farahmand F; Motamed F; Rohani P; Alimadadi H; Mahdaviani A; Mansouri M; Tavakol M; Vanderberg M; Kotlarz D; Klein C; Rezaei N
Immunol Invest; 2021 May; 50(4):445-459. PubMed ID: 32633164
[TBL] [Abstract][Full Text] [Related]
28. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
Ouahed J; Spencer E; Kotlarz D; Shouval DS; Kowalik M; Peng K; Field M; Grushkin-Lerner L; Pai SY; Bousvaros A; Cho J; Argmann C; Schadt E; Mcgovern DPB; Mokry M; Nieuwenhuis E; Clevers H; Powrie F; Uhlig H; Klein C; Muise A; Dubinsky M; Snapper SB
Inflamm Bowel Dis; 2020 May; 26(6):820-842. PubMed ID: 31833544
[TBL] [Abstract][Full Text] [Related]
29. Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing.
Dinwiddie DL; Bracken JM; Bass JA; Christenson K; Soden SE; Saunders CJ; Miller NA; Singh V; Zwick DL; Roberts CC; Dalal J; Kingsmore SF
Genomics; 2013; 102(5-6):442-7. PubMed ID: 24001973
[TBL] [Abstract][Full Text] [Related]
30. Whole exome sequencing (WES) approach for diagnosing primary immunodeficiencies (PIDs) in a highly consanguineous community.
Simon AJ; Golan AC; Lev A; Stauber T; Barel O; Somekh I; Klein C; AbuZaitun O; Eyal E; Kol N; Unal E; Amariglio N; Rechavi G; Somech R
Clin Immunol; 2020 May; 214():108376. PubMed ID: 32135276
[TBL] [Abstract][Full Text] [Related]
31. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
Kotlarz D; Beier R; Murugan D; Diestelhorst J; Jensen O; Boztug K; Pfeifer D; Kreipe H; Pfister ED; Baumann U; Puchalka J; Bohne J; Egritas O; Dalgic B; Kolho KL; Sauerbrey A; Buderus S; Güngör T; Enninger A; Koda YK; Guariso G; Weiss B; Corbacioglu S; Socha P; Uslu N; Metin A; Wahbeh GT; Husain K; Ramadan D; Al-Herz W; Grimbacher B; Sauer M; Sykora KW; Koletzko S; Klein C
Gastroenterology; 2012 Aug; 143(2):347-55. PubMed ID: 22549091
[TBL] [Abstract][Full Text] [Related]
32. Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children.
Nemati S; Teimourian S; Tabrizi M; Najafi M; Dara N; Imanzadeh F; Ahmadi M; Aghdam MK; Tavassoli M; Rohani P; Madani SR; de Boer M; Kuijpers TW; Roos D
Eur J Med Genet; 2017 Dec; 60(12):643-649. PubMed ID: 28864178
[TBL] [Abstract][Full Text] [Related]
33. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency.
Salzer E; Kansu A; Sic H; Májek P; Ikincioğullari A; Dogu FE; Prengemann NK; Santos-Valente E; Pickl WF; Bilic I; Ban SA; Kuloğlu Z; Demir AM; Ensari A; Colinge J; Rizzi M; Eibel H; Boztug K
J Allergy Clin Immunol; 2014 Jun; 133(6):1651-9.e12. PubMed ID: 24746753
[TBL] [Abstract][Full Text] [Related]
34. Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.
Ye Z; Zhou Y; Huang Y; Wang Y; Lu J; Tang Z; Miao S; Dong K; Jiang Z
Inflamm Bowel Dis; 2017 Dec; 23(12):2154-2164. PubMed ID: 29140941
[TBL] [Abstract][Full Text] [Related]
35. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
Serra EG; Schwerd T; Moutsianas L; Cavounidis A; Fachal L; Pandey S; Kammermeier J; Croft NM; Posovszky C; Rodrigues A; Russell RK; Barakat F; Auth MKH; Heuschkel R; Zilbauer M; Fyderek K; Braegger C; Travis SP; Satsangi J; Parkes M; Thapar N; Ferry H; Matte JC; Gilmour KC; Wedrychowicz A; Sullivan P; Moore C; Sambrook J; Ouwehand W; Roberts D; Danesh J; Baeumler TA; Fulga TA; Carrami EM; Ahmed A; Wilson R; Barrett JC; Elkadri A; Griffiths AM; ; ; ; ; ; ; Snapper SB; Shah N; Muise AM; Wilson DC; Uhlig HH; Anderson CA
Nat Commun; 2020 Feb; 11(1):995. PubMed ID: 32081864
[TBL] [Abstract][Full Text] [Related]
36. Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review.
Lekbua A; Ouahed J; O'Connell AE; Kahn SA; Goldsmith JD; Imamura T; Duncan CN; Kelsen JR; Worthey E; Snapper SB; Softic S
J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):e13-e18. PubMed ID: 31232887
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers.
Aguilar C; Lenoir C; Lambert N; Bègue B; Brousse N; Canioni D; Berrebi D; Roy M; Gérart S; Chapel H; Schwerd T; Siproudhis L; Schäppi M; Al-Ahmari A; Mori M; Yamaide A; Galicier L; Neven B; Routes J; Uhlig HH; Koletzko S; Patel S; Kanegane H; Picard C; Fischer A; Bensussan NC; Ruemmele F; Hugot JP; Latour S
J Allergy Clin Immunol; 2014 Nov; 134(5):1131-41.e9. PubMed ID: 24942515
[TBL] [Abstract][Full Text] [Related]
38. Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected Findings.
Rudilla F; Franco-Jarava C; Martínez-Gallo M; Garcia-Prat M; Martín-Nalda A; Rivière J; Aguiló-Cucurull A; Mongay L; Vidal F; Solanich X; Irastorza I; Santos-Pérez JL; Tercedor Sánchez J; Cuscó I; Serra C; Baz-Redón N; Fernández-Cancio M; Carreras C; Vagace JM; Garcia-Patos V; Pujol-Borrell R; Soler-Palacín P; Colobran R
Front Immunol; 2019; 10():2325. PubMed ID: 31681265
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic stem cell transplantation for CYBB heterozygous mutation resulting in very early onset inflammatory bowel disease in children: a case report.
Li Z; Chen H; Feng X; Ruan Y; Yang M
BMC Pediatr; 2023 Jul; 23(1):348. PubMed ID: 37434114
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review.
Both T; Dalm VASH; Richardson SA; van Schie N; van den Broek LM; de Vries AC; van Hagen PM; Rombach SM
Autoimmun Rev; 2021 Aug; 20(8):102872. PubMed ID: 34118459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
